MSc, Healthcare Management
BSc, Health and Sports Studies
University of Huddersfield, Huddersfield, United Kingdom
Liesl Gildea has experience in a range of therapy areas, including cardiovascular disease, oncology, coeliac disease, tick-borne encephalitis, bullous pemphigoid, myelofibrosis, psoriasis, respiratory disease, ulcerative colitis, COVID-19, and medical devices. In her current role, Ms. Gildea is involved in primary and secondary research to support the development of evidence-based dossiers, systematic and targeted literature reviews, health technology assessment submissions (including Nordic submissions), and health economics and outcomes research strategies. Before joining RTI-HS, Ms. Gildea was a health technology assessment analyst at the National Institute for Health and Care Excellence (NICE), specialising in the evaluation of medical devices for use in the UK’s National Health Service (NHS).